Ally Bridge Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Ally Bridge Group's RGEN Position: Q1 2023 in Review
Ally Bridge Group sold out of Repligen (RGEN) in Q1 2023, closing a stake of 12,180 shares — an estimated $2.06M sold.
Ally Bridge Group first reported a position in RGEN in Q4 2020 and held it in 7 quarters. The position peaked at $20.2M in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.
- Ally Bridge Group reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
- Ally Bridge Group sold 12,180 Repligen shares in Q1 2023, an estimated $2.06M.
- Ally Bridge Group first reported a position in Repligen in Q4 2020 and held it in 7 quarters.
- Ally Bridge Group's Repligen position peaked at $20.2M in Q3 2021.
- 446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.
Based on Ally Bridge Group's 13F filing for Q1 2023, filed 15 May 2023.